In May 2021, The Currency revealed that Pfizer would conduct part of the manufacturing process for its successful Covid-19 in Ireland. Six months after the first authorisation of the vaccine developed by the US pharmaceutical giant and its German partner BioNTech, the global race to immunise populations required large-scale production, and Dublin’s Grange Castle plant was among the sites to benefit from this surge in business. Pfizer’s resulting profits contributed to the unprecedented jump in Ireland’s corporation tax receipts to the record €22.6 billion collected last year. The latest tax take figures from the Department of Finance show that this…

Want to continue reading?

Join today with an Annual membership and get full access to The Currency for just €200 (68c per day) or try monthly membership for just €5 for your first month.

Subscribe

Cancel at any time.

Are you already a member? .